Business Wire

NTT: World’s First Successful 1.4-Tbit/s Wireless Transmission in the Sub-THz Band

Share

Aiming to implement terabit-class wireless transmission to support wireless demand in the 2030s, NTT Corporation (NTT) has successfully achieved the world’s first “orbital angular momentum (OAM) multiplexing high-capacity wireless transmission—at 1.44 Tbit/s—using an ultra-wide bandwidth of 32 GHz. As an innovative wireless-communication technology that uses the sub-terahertz (sub-THz) band, this achievement will enable wireless access to vast amounts of information at data-transfer rate exceeding 1 Tbit/s. This achievement was realized using the sub-THz band within the range from 135 GHz to 170 GHz, and is an innovative wireless communication technology that enables wireless access to a huge amount of information exceeding 1 Tbit/s. As a key element of the “Innovative Optical and Wireless Network” (IOWN), which we aim to implement with our global partners, it is an extension of the high-capacity communication network and information-processing infrastructure centered on light to wireless networks including 6G.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420006084/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Figure 1: Image of OAM-multiplexing transmission technology and trends in high-capacity wireless transmission (Graphic: Business Wire)

Aiming to support the high-capacity network and information processing infrastructure of the IOWN and 6G and prepare for the increasing future demand for wireless communications, NTT is engaged in research and development with the goal of achieving terabit-class wireless transmission. To enhance the capacity of wireless communications, NTT is increasing the spatial multiplexing order by applying on a new principle using radio waves with “orbital angular momentum” (Figure 1) to increase wireless-transmission capacity and using the sub-terahertz (sub-THz) band to increase transmission bandwidth.

The approach taken by NTT is to use an analog circuit called a “Butler matrix” to increase the spatial multiplexing order by multiplexing multiple OAM waves. This approach reduces the enormous amount of digital signal processing required to eliminate interference between multiplexed data streams in high-capacity communications exceeding one terabit.

In this research, NTT has promoted research and development of sub-THz-band waveguide technology and succeeded in developing an antenna-integrated Butler matrix that operates with a wide bandwidth and low loss. The antenna-integrated Butler matrix is designed to simultaneously generate and separate eight different OAM waves over a very wide bandwidth, i.e., 135 to 170 GHz, which can be used to multiplex and transmit eight data signals. Moreover, by performing OAM multiplexing transmission with two different polarizations, it is possible to multiplex and transmit twice as many data signals simultaneously without them interfering. We conducted transmission tests using the antenna-integrated Butler matrix, and we achieved the world’s first successful large-capacity wireless transmission totaling 1.44 Tbit/s in the sub-THz bands of 135.5 to 151.5 GHz and 152.5 to 168.5 GHz (Figure 2). This transmission capacity is equivalent to the speed of simultaneous transmission of approximately 35,000 ultra-high-definition 4K videos (at about 40 Mbit/s) that can be available on current video websites. This speed enables the simultaneous transmission of 140 or more uncompressed 4K videos (at about 10 Gbit/s) for applications that require ultra-low latency.

This technology is expected to enable (i) broadband and high-speed wireless transmission comparable to optical transmission systems and (ii) seamless connection between wireless and optical transmission systems without the need for a complex digital signal-processing system for spatial multiplexing, since the analog circuit (i.e., the Butler matrix) handles the multiplexing of OAM waves. The next step in this development is to conduct demonstrations over longer distances (exceeding 100 m) while envisioning various applications of this technology in the real world, including wireless backhaul/fronthaul between base stations and relay transmission (Figure 3). We expect the eventual development of this technology to support the creation and spread of various future services, such as VR/AR (virtual reality/augmented reality), high-definition video transmission, connected cars, and telemedicine, as innovative wireless-communication technology in the IOWN and 6G era.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

[Media Contact]
NTT Corporation,
Science and Core Technology Laboratory Group,
nttrd-pr@ml.ntt.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The Patient Safety Movement Foundation Concludes Its 10th Annual World Patient Safety, Science & Technology Summit3.6.2023 08:11:00 EEST | Press release

President Bill Clinton, 42nd President of the United States, headlined day two of the 10th Annual World Patient Safety, Science & Technology Summit, presented by the Patient Safety Movement Foundation (PSMF). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230602005417/en/ Joe Kiani, founder of the Patient Safety Movement Foundation, discusses efforts to improve patient safety worldwide with former President Bill Clinton at the 10th Annual World Patient Safety, Science & Technology Summit in Newport Beach, California. (Photo: Business Wire) As a long-time advocate of patient safety, President Clinton spoke of the need to develop what he termed a “culture of conversion,” where more people within healthcare feel empowered to implement proven practices for eliminating preventable harm within hospitals. “We know enough right now to cut the current problem by half or more,” he said. “One of the biggest problems you have in every b

Ilsong Educational Foundation Chairman Dai-Won Yoon Wins Linnaeus Medal as the First in Asia2.6.2023 12:00:00 EEST | Press release

On May 30, Chairman Dai-Won Yoon of Ilsong Educational Foundation received the Linnaeus Medal from Uppsala University at Hallym University. This makes him the first person from Asia to receive the award. Ilsong Educational Foundation operates Hallym University and Hallym University Medical Center. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230531005495/en/ Chairman Dai-Won Yoon (left) of Ilsong Educational Foundation received Linnaeus Medal as the 1st in Asia (Photo: Hallym University) Chairman Yoon is the honoree of 2020. The award ceremony, which had been postponed due to COVID-19, was held this year with a delegation led by Vice Chancellor Anders Hagfeldt of Uppsala University visiting Korea. The Linnaeus Medal to commemorate Carl Linnaeus, a Swedish botanist, is awarded annually by Uppsala University to a person who has made a significant contribution to the field of science. Chairman Yoon was honored for his work in

10th Annual World Patient Safety, Science & Technology Summit Begins2.6.2023 09:15:00 EEST | Press release

Day one of the 10th Annual World Patient Safety, Science & Technology Summit presented by the Patient Safety Movement Foundation (PSMF) saw global leaders across the world of patient safety call for an increased urgency in addressing the issue of preventable harm within healthcare. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601006140/en/ Joe Kiani, founder of the Patient Safety Movement Foundation, speaks at the 10th Annual World Patient Safety, Science & Technology Summit in Newport Beach, California. (Photo: Business Wire) Celebrating the PSMF’s 10th anniversary, Dr. Michael Ramsay, chief executive officer of the PSMF, reflected on the role that the increasing availability of hospital data on medical errors could play in reducing harm. “I’m very optimistic that we’re really going to see a difference in healthcare,” he said. “Technology is changing. We’re now getting real data. We know what the outcomes are in hospit

Autel Energy Holds Partner Summit in Amsterdam, Mapping Out Europe Strategy2.6.2023 09:00:00 EEST | Press release

Autel Energy, a leading provider of EV charging products and services, successfully hosted the Autel Partner Summit at Muziekgebouw in Amsterdam from May 31 to June 1, 2023. The event not only showcased Autel’s visionary Europe strategy for the next two years but also provided partners opportunities to gain insights into the company's vision, and learn about Autel’s new products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005428/en/ A quick afternoon bite with the Autel partners. (Photo: Business Wire) The Partner Summit helped Autel Energy to strengthen its partnerships in Europe and highlighted its collaborations with key clients. Notable partners in attendance included Maxicharger AC clients such as Sevadis and Deta, as well as Maxicharger DC clients such as Floading, Gasgas, and eWays. The company also partnered with CPO clients like Fastway and Powerdo, as well as energy companies like Enefit. The Summit was d

PL BioScience and Macopharma enter into a Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements.2.6.2023 08:22:00 EEST | Press release

PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License and Assignment Agreement with the French company Macopharma S.A.S. As a result of the Agreement, PL BioScience will hereby accept a worldwide license under the patents filed by Macopharma, with a right to sublicense (through multiple tiers), for the duration of the license period. In addition to the Patent License and Assignment Agreement, Macopharma will introduce PL BioScience to their current HPL customers, and thanks to a comprehensive comparative evaluation showing equivalence of HPL products from PL BioScience, Macopharma HPL customers will have the opportunity to transfer their future orders to PL BioScience with minimal disruption. About PL BioScience: Located in Aachen in Germany, PL BioScience GmbH is a life science company specializing in the production and development of Human Platelet Lysate (HP

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom